Holen Sie sich die Stockscreener-App
3.44
4.97%
-0.18
Polypid Ltd Aktie (PYPD) Neueste Nachrichten
PolyPid to Participate in Three Upcoming Fall Investor Conferences - GlobeNewswire
PolyPid to Participate in Three Upcoming Fall Investor Conferences - StockTitan
Equities Analysts Offer Predictions for PolyPid Ltd.’s Q3 2024 Earnings (NASDAQ:PYPD) - Defense World
HC Wainwright Reiterates “Buy” Rating for PolyPid (NASDAQ:PYPD) - Defense World
PolyPid Ltd. (NASDAQ:PYPD) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: PolyPid reports a net loss of $6.3 million in the second-quarter of 2024 - Investing.com
Earnings call: PolyPid reports a net loss of $6.3 million in the second-quarter of 2024 - Investing.com India
Earnings call: PolyPid reports a net loss of $6.3 million in the second-quarter of 2024 - Investing.com Canada
PolyPid Reports Growth in Mid-Year Assets - TipRanks
PolyPid Advances SHIELD II Trial with Solid Financing - TipRanks
PolyPid Provides Corporate Update and Reports Second Quarter 2024 Financial Results - GlobeNewswire
PolyPid Provides Corporate Update and Reports Second Quarter 2024 Financial Results - StockTitan
PolyPid Provides Corporate Update and Reports Second Quarter 2024 Financial Results - Yahoo Finance
Analyzing Silk Road Medical (NASDAQ:SILK) & PolyPid (NASDAQ:PYPD) - Defense World
PolyPid (PYPD) Scheduled to Post Earnings on Wednesday - Defense World
PolyPid secures $14 million in private placement - Investing.com
PolyPid secures $14 million in private placement By Investing.com - Investing.com UK
PolyPid Secures Funding, Extends Runway for D-PLEX100 Trial - TipRanks
PolyPid Announces Private Placement for Up to $14 Million in Gross Proceeds - StockTitan
PolyPid Announces Private Placement for Up to $14 Million in Gross Proceeds - GlobeNewswire
PolyPid to Report Second Quarter 2024 Financial Results and Operational Highlights on August 14, 2024 - GlobeNewswire
PolyPid to Report Second Quarter 2024 Financial Results and Operational Highlights on August 14, 2024 - StockTitan
PolyPid to Report Second Quarter 2024 Financial Results and Operational Highlights on August 14, 2024 - Yahoo Finance
PolyPid stock hits 52-week low at $3.35 amid market challenges - Investing.com
PolyPid stock hits 52-week low at $3.35 amid market challenges - Investing.com India
PolyPid (NASDAQ:PYPD) Trading 1.7% Higher - Defense World
PolyPid Ends Equity Sales Agreement, No Penalties Incurred - TipRanks
PolyPid Revamps Share Option Plan for Stakeholders - TipRanks
Critical Comparison: PolyPid (NASDAQ:PYPD) versus GBS (NYSE:GBS) - Defense World
PolyPid Ltd. (NASDAQ:PYPD) Forecasted to Post Q2 2024 Earnings of ($1.51) Per Share - Defense World
PolyPid hosts KOL call, provides update on ongoing SHIELD II Phase 3 trialTipRanks.com - TipRanks
Superficial Punctate Keratitis Market Size 2032 | Market Drivers & Barriers, Clinical Trials and Latest Drugs - EIN News
PolyPid Advances Trial for Infection PreventionTipRanks.com - TipRanks
PolyPid Hosts KOL Call to Discuss Significant Unmet Medical Need in Surgical Site Infections Prevention and Provides ... - GlobeNewswire
PolyPid Hosts KOL Call to Discuss Significant Unmet Medical Need in Surgical Site Infections Prevention and Provides ... - Yahoo Finance
Comparing PolyPid (NASDAQ:PYPD) and Nemaura Medical (NASDAQ:NMRD) - Defense World
PolyPid to Host Virtual KOL Event on June 17, 2024, and Provide an Update on the Company's Ongoing D-PLEX₁₀₀ ... - GlobeNewswire
PolyPid to Host Virtual KOL Event on June 17, 2024, and Provide an Update on the Company's Ongoing D-PLEX₁₀₀ ... - StockTitan
PolyPid to Host Virtual KOL Event on June 17, 2024, and Provide an Update on the Company's Ongoing D-PLEX₁₀₀ ... - Yahoo Finance
Wall Street Analysts Think PolyPid Ltd. (PYPD) Could Surge 289%: Read This Before Placing a Bet - Yahoo News UK
PolyPid Ltd. Schedules Shareholder MeetingTipRanks.com - TipRanks
PolyPid Enhances Share Option Plan to Motivate StaffTipRanks.com - TipRanks
Is Liquidia Technologies (LQDA) Outperforming Other Medical Stocks This Year? - Yahoo News UK
PolyPid (NASDAQ:PYPD) Earns Buy Rating from HC Wainwright - Defense World
How Much Of PolyPid Ltd. (NASDAQ:PYPD) Do Insiders Own? - Yahoo Lifestyle UK
PolyPid Ltd. (NASDAQ:PYPD) Q1 2024 Earnings Call Transcript - Insider Monkey
Earnings call: PolyPid reports progress in D-PLEX100 trial, eyes expansion - Investing.com
PolyPid Ltd (PYPD) Q1 2024 Earnings Call Transcript - Seeking Alpha
PolyPid Advances Phase 3 Trial, Strengthens FinancesTipRanks.com - TipRanks
PolyPid Provides Corporate Update and Reports First Quarter 2024 Financial Results - GlobeNewswire
PolyPid Provides Corporate Update and Reports First Quarter 2024 Financial Results - Yahoo Finance
PolyPid (NASDAQ:PYPD) Earns “Buy” Rating from HC Wainwright - Defense World
PolyPid to Participate in Citizens JMP Life Sciences Conference - Yahoo Finance
PolyPid Advances Phase 3 Trial, Eyes Future FundingTipRanks.com - TipRanks
PolyPid Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the ... - GlobeNewswire
PolyPid Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections - GlobeNewswire Inc.
PolyPid Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the ... - Yahoo Finance
PolyPid to Report First Quarter 2024 Financial Results and Operational Highlights on May 8, 2024 - GlobeNewswire Inc.
Jaguar Health stock gains as reverse stock split cleared - Seeking Alpha
PolyPid to Participate in Barclays 26th Annual Global Healthcare Conference - GlobeNewswire
PolyPid Ltd. (NASDAQ:PYPD) Q4 2023 Earnings Call Transcript - Yahoo Finance
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewswire
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Markets Insider
Earnings call: PolyPid's Q3 2023 financial results show decreased expenses and progress in SHIELD II trial - Investing.com India
0.05%
4.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):